| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX4 SOX15 TSHZ3 SALL3 TSHZ2 ZBTB22 POU4F2 LHX6 IRX4 MSGN1 HOXB2 HOXB3 ATF6 SALL2 NEUROG1 EGR1 NFATC3 NFIB YLPM1 ZNF558 PAX2 ELK3 CUX1 | 1.00e-05 | 1412 | 120 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.42e-05 | 25 | 120 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 4.48e-05 | 12 | 120 | 3 | GO:1990817 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | SOX4 SOX15 POU4F2 MSGN1 HOXB2 HOXB3 ATF6 SALL2 EGR1 NFATC3 NFIB ELK3 | 1.42e-04 | 560 | 120 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | chromatin binding | SOX15 TSHZ3 ATRX POU4F2 ARID1A WAC MSGN1 NEUROG1 EGR1 NFATC3 KMT2A ASXL2 CABIN1 CUX1 | 1.42e-04 | 739 | 120 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SOX4 SOX15 POU4F2 MSGN1 HOXB2 HOXB3 ATF6 SALL2 EGR1 NFATC3 NFIB ELK3 | 1.56e-04 | 566 | 120 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 3.11e-04 | 54 | 120 | 4 | GO:0030159 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | LIMD1 SH2B3 BCLAF1 ITSN1 NACA TUT1 ZC3H18 SORBS1 MED13L SRCAP ARID1A HCN2 SH2B2 PPARGC1B LAT SETD5 HGS DYRK1B CUX1 | 4.57e-04 | 1356 | 120 | 19 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 5.57e-04 | 27 | 120 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | LIMD1 SH2B3 BCLAF1 NACA TUT1 ZC3H18 SORBS1 MED13L SRCAP ARID1A SH2B2 PPARGC1B LAT SETD5 HGS DYRK1B CUX1 | 5.68e-04 | 1160 | 120 | 17 | GO:0030674 |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 8.41e-04 | 31 | 120 | 3 | GO:0070566 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX4 SOX15 SALL3 ZBTB22 POU4F2 LHX6 IRX4 MSGN1 HOXB3 ATF6 SALL2 NEUROG1 EGR1 NFATC3 NFIB ZNF558 PAX2 ELK3 CUX1 | 1.11e-03 | 1459 | 120 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX4 SOX15 SALL3 ZBTB22 POU4F2 IRX4 MSGN1 HOXB3 ATF6 SALL2 NEUROG1 EGR1 NFATC3 NFIB PAX2 ELK3 CUX1 | 1.23e-03 | 1244 | 120 | 17 | GO:0000978 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.42e-03 | 37 | 120 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX4 SOX15 SALL3 ZBTB22 POU4F2 IRX4 MSGN1 HOXB3 ATF6 SALL2 NEUROG1 EGR1 NFATC3 NFIB PAX2 ELK3 CUX1 | 1.55e-03 | 1271 | 120 | 17 | GO:0000987 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX4 SOX15 TSHZ3 LIMD1 BCLAF1 RBM10 NACA POU4F2 ARID1A IRX4 ZNF503 HOXB3 PPARGC1B SALL2 EGR1 NFATC3 SETD5 NFIB YLPM1 PAX2 ASXL2 ELK3 PRDM6 CUX1 | 1.05e-06 | 1399 | 118 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX4 SOX15 TSHZ3 LIMD1 BCLAF1 RBM10 NACA POU4F2 ARID1A IRX4 ZNF503 HOXB3 PPARGC1B SALL2 EGR1 NFATC3 SETD5 NFIB YLPM1 PAX2 ASXL2 ELK3 PRDM6 CUX1 | 1.26e-06 | 1413 | 118 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX4 SOX15 ATRX BCLAF1 NACA POU4F2 MAP3K1 MSGN1 HOXB2 HOXB3 ATF6 PPARGC1B SALL2 NEUROG1 EGR1 NFATC3 LMO7 MICAL2 NFIB KMT2A PAX2 ASXL2 ELK3 | 3.39e-06 | 1390 | 118 | 23 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX4 SOX15 RBM10 NACA POU4F2 ARID1A IRX4 HOXB3 SALL2 EGR1 NFATC3 NFIB YLPM1 PAX2 ASXL2 ELK3 PRDM6 CUX1 | 2.98e-05 | 1053 | 118 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | cranial nerve morphogenesis | 3.23e-05 | 32 | 118 | 4 | GO:0021602 | |
| GeneOntologyBiologicalProcess | pattern specification process | ACD IRX4 MSGN1 HOXB2 HOXB3 CELSR1 NEUROG1 MICAL2 KMT2A ROBO1 PAX2 DISP1 | 4.91e-05 | 526 | 118 | 12 | GO:0007389 |
| GeneOntologyBiologicalProcess | regionalization | ACD MSGN1 HOXB2 HOXB3 CELSR1 NEUROG1 MICAL2 KMT2A ROBO1 PAX2 DISP1 | 9.51e-05 | 478 | 118 | 11 | GO:0003002 |
| GeneOntologyBiologicalProcess | nuclear pore organization | 1.40e-04 | 18 | 118 | 3 | GO:0006999 | |
| GeneOntologyCellularComponent | chromatin | SOX4 SOX15 TSHZ3 ATRX TSHZ2 ZBTB22 POU4F2 SRCAP ARID1A LHX6 IRX4 MSGN1 HOXB2 HOXB3 ATF6 NEUROG1 EGR1 NFATC3 SETD5 NFIB PAX2 ELK3 CUX1 AFF4 | 2.62e-06 | 1480 | 119 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TENT4B ACD BCLAF1 TUT1 MED13L SRCAP ARID1A POM121C WAC ATF6 PPARGC1B POM121 LAT SETD5 GLE1 DROSHA KMT2A ASXL2 NUP188 POM121B AFF4 | 3.07e-05 | 1377 | 119 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear pore | 2.82e-04 | 101 | 119 | 5 | GO:0005643 | |
| HumanPheno | Hirsutism | 6.01e-05 | 216 | 43 | 9 | HP:0001007 | |
| HumanPheno | Congenital malformation of the great arteries | SOX4 RBM10 SPECC1L MED13L SRCAP ARID1A WAC KMT2A ROBO1 ASXL2 PRDM6 DISP1 CUX1 AFF4 | 6.46e-05 | 529 | 43 | 14 | HP:0011603 |
| HumanPheno | Thin upper lip vermilion | SOX4 ATRX SPECC1L SRCAP ARID1A WAC SETD5 KMT2A ASXL2 CUX1 AFF4 | 8.03e-05 | 339 | 43 | 11 | HP:0000219 |
| HumanPheno | Thin lips | SOX4 ATRX SPECC1L SRCAP ARID1A WAC SETD5 KMT2A ASXL2 CUX1 AFF4 | 8.03e-05 | 339 | 43 | 11 | HP:0000213 |
| Domain | LIM | 6.66e-05 | 69 | 115 | 5 | PF00412 | |
| Domain | - | 7.13e-05 | 70 | 115 | 5 | 2.10.110.10 | |
| Domain | LIM | 7.64e-05 | 71 | 115 | 5 | SM00132 | |
| Domain | Znf_LIM | 7.64e-05 | 71 | 115 | 5 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 7.64e-05 | 71 | 115 | 5 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 7.64e-05 | 71 | 115 | 5 | PS50023 | |
| Domain | Homeobox | 1.01e-04 | 234 | 115 | 8 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.07e-04 | 236 | 115 | 8 | PS00027 | |
| Domain | HOX | 1.10e-04 | 237 | 115 | 8 | SM00389 | |
| Domain | Phe_ZIP | 1.12e-04 | 3 | 115 | 2 | PF08916 | |
| Domain | Teashirt_fam | 1.12e-04 | 3 | 115 | 2 | IPR027008 | |
| Domain | Phe_ZIP | 1.12e-04 | 3 | 115 | 2 | IPR015012 | |
| Domain | SH2B | 1.12e-04 | 3 | 115 | 2 | IPR030523 | |
| Domain | HOMEOBOX_2 | 1.17e-04 | 239 | 115 | 8 | PS50071 | |
| Domain | Homeobox_dom | 1.17e-04 | 239 | 115 | 8 | IPR001356 | |
| Domain | Homeodomain-like | 2.14e-04 | 332 | 115 | 9 | IPR009057 | |
| Domain | - | 3.67e-04 | 283 | 115 | 8 | 1.10.10.60 | |
| Domain | CH | 6.91e-04 | 65 | 115 | 4 | SM00033 | |
| Domain | PAP_assoc | 7.74e-04 | 7 | 115 | 2 | PF03828 | |
| Domain | PAP_assoc | 7.74e-04 | 7 | 115 | 2 | IPR002058 | |
| Domain | CH | 9.15e-04 | 70 | 115 | 4 | PF00307 | |
| Domain | - | 9.65e-04 | 71 | 115 | 4 | 1.10.418.10 | |
| Domain | Homeobox_CS | 1.03e-03 | 186 | 115 | 6 | IPR017970 | |
| Domain | CH | 1.07e-03 | 73 | 115 | 4 | PS50021 | |
| Domain | CH-domain | 1.18e-03 | 75 | 115 | 4 | IPR001715 | |
| Domain | VHS | 1.32e-03 | 9 | 115 | 2 | PS50179 | |
| Domain | VHS | 1.32e-03 | 9 | 115 | 2 | PF00790 | |
| Domain | VHS | 1.32e-03 | 9 | 115 | 2 | SM00288 | |
| Domain | VHS_dom | 1.32e-03 | 9 | 115 | 2 | IPR002014 | |
| Domain | - | 1.84e-03 | 449 | 115 | 9 | 3.30.40.10 | |
| Domain | NTP_transf_2 | 1.99e-03 | 11 | 115 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 1.99e-03 | 11 | 115 | 2 | IPR002934 | |
| Domain | SET | 2.04e-03 | 41 | 115 | 3 | PF00856 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.56e-05 | 24 | 91 | 4 | MM15658 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 6.11e-05 | 65 | 91 | 5 | M39682 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.24e-04 | 40 | 91 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.37e-04 | 41 | 91 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.51e-04 | 42 | 91 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.65e-04 | 43 | 91 | 4 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.31e-04 | 86 | 91 | 5 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.34e-04 | 47 | 91 | 4 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.76e-04 | 49 | 91 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.98e-04 | 50 | 91 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.22e-04 | 51 | 91 | 4 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.31e-04 | 55 | 91 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.28e-04 | 58 | 91 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.28e-04 | 58 | 91 | 4 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 8.15e-04 | 65 | 91 | 4 | MM15147 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 8.47e-04 | 114 | 91 | 5 | MM15361 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 9.31e-04 | 30 | 91 | 3 | M47752 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 9.65e-04 | 68 | 91 | 4 | MM14921 | |
| Pubmed | SOX4 SOX15 TSHZ3 ATRX LIMD1 ADRM1 RBM10 NACA COP1 ZC3H18 SRCAP ARID1A POM121C LHX6 ZNF503 RNF214 UBE2O SALL2 DCP1B ATXN2 NFATC3 NFIB PRRC2C HGS YLPM1 KMT2A PAX2 ASXL2 ELK3 CABIN1 CUX1 | 1.11e-16 | 1429 | 120 | 31 | 35140242 | |
| Pubmed | LIMD1 RBM10 ITSN1 KIAA1549 ARID1A POM121C GGA3 GORASP2 UBE2O POM121 ATXN2 HGS TMEM131 DNMBP | 4.64e-13 | 263 | 120 | 14 | 34702444 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 RAPGEF6 GBF1 SH2B3 MYCBP2 TBC1D25 LRRK1 MED13L SRCAP ARID1A POM121C SH2B2 GGA3 ZNF503 TLK1 PHLDB1 CELSR1 SETD5 PAX2 NUP188 CABIN1 DNMBP LTBP4 PRRT4 | 5.22e-13 | 1105 | 120 | 24 | 35748872 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX4 SOX15 TSHZ3 TSHZ2 KIAA1549 POU4F2 LHX6 IRX4 MSGN1 HOXB2 HOXB3 ATF6 SALL2 NEUROG1 EGR1 NFATC3 NFIB KMT2A PAX2 ELK3 | 4.44e-11 | 908 | 120 | 20 | 19274049 |
| Pubmed | ATRX MYCBP2 ITSN1 NCKAP5 SORBS1 MED13L ARID1A FAF1 WAC ATF6 GORASP2 UBE2O LMO7 MICAL2 DROSHA YLPM1 USP32 ZNF558 ROBO1 TMEM131 CABIN1 CUX1 AFF4 | 8.17e-11 | 1285 | 120 | 23 | 35914814 | |
| Pubmed | RAPGEF6 LIMD1 MYCBP2 MAP4 BCLAF1 RBM10 SPECC1L SRCAP ARID1A GGA3 UBE2O LMO7 PRRC2C YLPM1 KMT2A CUX1 | 8.21e-11 | 549 | 120 | 16 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAPGEF6 GBF1 SFSWAP ATRX MYCBP2 MAP4 BCLAF1 RBM10 ITSN1 ZC3H18 PAPOLG TLK1 LMO7 YLPM1 KMT2A TJAP1 ELK3 DNMBP | 1.93e-10 | 774 | 120 | 18 | 15302935 |
| Pubmed | ITSN1 EVPL NCKAP5 SORBS1 SPECC1L POM121C ATF6 TLK1 POM121 EGR1 HGS DYRK1B ROBO1 CUX1 | 1.56e-09 | 486 | 120 | 14 | 20936779 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATRX ITSN1 ZC3H18 SORBS1 SRCAP ARID1A PAPOLG SALL2 NFATC3 LMO7 DROSHA PRRC2C BSN DNMBP | 1.73e-08 | 588 | 120 | 14 | 38580884 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 ATRX LIMD1 MAP4 BCLAF1 RBM10 NACA SRCAP POM121C WAC GGA3 GORASP2 UBE2O PRRC2C YLPM1 KMT2A AFF4 | 2.43e-08 | 934 | 120 | 17 | 33916271 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | BCLAF1 RBM10 ZC3H18 SRCAP ARID1A POM121C WAC YLPM1 KMT2A NUP188 AFF4 | 3.07e-08 | 341 | 120 | 11 | 32971831 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TSHZ3 RAPGEF6 GBF1 ITSN1 POM121C MAP3K1 GGA3 POM121 EGR1 ATXN2 YLPM1 BSN | 3.47e-08 | 430 | 120 | 12 | 35044719 |
| Pubmed | MYCBP2 BCLAF1 ITSN1 ZBTB22 SORBS1 SPECC1L HCN2 UBE2O ATXN2 NFATC3 PRRC2C YLPM1 TJAP1 BSN CABIN1 CUX1 AFF4 | 3.77e-08 | 963 | 120 | 17 | 28671696 | |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 4.01e-08 | 3 | 120 | 3 | 30802453 | |
| Pubmed | 4.01e-08 | 3 | 120 | 3 | 35507432 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 GBF1 LIMD1 MYCBP2 MAP4 SORBS1 RAB11FIP1 MAP3K6 PHLDB1 DCP1B NFATC3 LMO7 PRRC2C DYRK1B KMT2A DNMBP | 4.89e-08 | 861 | 120 | 16 | 36931259 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | SOX4 ZBTB22 LHX6 MSGN1 HOXB2 ATF6 NEUROG1 EGR1 NFATC3 NFIB PAX2 ELK3 CUX1 | 5.55e-08 | 544 | 120 | 13 | 28473536 |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.60e-07 | 4 | 120 | 3 | 17900573 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATRX LIMD1 MYCBP2 MAP4 TSHZ2 ARID1A FAF1 ATF6 PPARGC1B TLK1 PHLDB1 ATXN2 SETD5 MICAL2 NFIB TJAP1 SNTG2 ELK3 CUX1 AFF4 | 1.86e-07 | 1489 | 120 | 20 | 28611215 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 2.06e-07 | 38 | 120 | 5 | 12791264 | |
| Pubmed | 4.16e-07 | 268 | 120 | 9 | 33640491 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SFSWAP ACD ATRX BCLAF1 RBM10 ZC3H18 SRCAP ARID1A POM121C WAC LMO7 NFIB YLPM1 KMT2A ASXL2 NUP188 CABIN1 CUX1 | 4.97e-07 | 1294 | 120 | 18 | 30804502 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | ARID1A POM121C ZNF503 POM121 DCP1B ATXN2 GLE1 NFIB PRRC2C YLPM1 NUP188 | 5.74e-07 | 457 | 120 | 11 | 32344865 |
| Pubmed | Zinc finger protein sall2 is not essential for embryonic and kidney development. | 7.95e-07 | 6 | 120 | 3 | 12482961 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SALL3 SFSWAP ATRX MAP4 BCLAF1 RBM10 ZC3H18 ARID1A WAC ATXN2 PRRC2C YLPM1 KMT2A CUX1 AFF4 | 1.09e-06 | 954 | 120 | 15 | 36373674 |
| Pubmed | Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. | 1.13e-06 | 53 | 120 | 5 | 21532573 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | GBF1 LIMD1 MYCBP2 MAP4 BCLAF1 SPECC1L RNF214 ATXN2 LMO7 PRRC2C YLPM1 TMEM131 DNMBP | 1.41e-06 | 724 | 120 | 13 | 36232890 |
| Pubmed | MYCBP2 ITSN1 NACA ZNF503 PAPOLG GORASP2 UBE2O DCP1B GLE1 HGS YLPM1 ROBO1 TMEM131 | 1.61e-06 | 733 | 120 | 13 | 34672954 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATRX MYCBP2 BCLAF1 RBM10 SRCAP ARID1A POM121C POM121 YLPM1 NUP188 | 3.19e-06 | 440 | 120 | 10 | 34244565 |
| Pubmed | 3.89e-06 | 263 | 120 | 8 | 20932939 | ||
| Pubmed | The zinc-finger transcription factor GLI3 is a regulator of precerebellar neuronal migration. | 3.95e-06 | 31 | 120 | 4 | 30470704 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 4.50e-06 | 358 | 120 | 9 | 32460013 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.55e-06 | 123 | 120 | 6 | 26912792 | |
| Pubmed | MYCBP2 MAP4 BCLAF1 RBM10 MED13L ARID1A WAC ZNF503 TLK1 EGR1 ATXN2 PRRC2C KMT2A ASXL2 CUX1 | 6.36e-06 | 1103 | 120 | 15 | 34189442 | |
| Pubmed | 6.50e-06 | 35 | 120 | 4 | 11013070 | ||
| Pubmed | Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. | 6.50e-06 | 35 | 120 | 4 | 19862010 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.66e-06 | 283 | 120 | 8 | 30585729 | |
| Pubmed | SOX4 LIMD1 ZBTB22 TUT1 ARID1A IRX4 SALL2 LMO7 KMT2A PAX2 ELK3 CUX1 | 6.66e-06 | 709 | 120 | 12 | 22988430 | |
| Pubmed | 7.45e-06 | 134 | 120 | 6 | 19030180 | ||
| Pubmed | Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. | 8.61e-06 | 12 | 120 | 3 | 11688560 | |
| Pubmed | 9.09e-06 | 38 | 120 | 4 | 11779826 | ||
| Pubmed | 1.07e-05 | 399 | 120 | 9 | 35987950 | ||
| Pubmed | Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus. | 1.18e-05 | 2 | 120 | 2 | 23844121 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 9730625 | ||
| Pubmed | Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. | 1.18e-05 | 2 | 120 | 2 | 16685377 | |
| Pubmed | Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer. | 1.18e-05 | 2 | 120 | 2 | 30019121 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 26482852 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 11944987 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 34576144 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21423795 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 22916186 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.31e-05 | 148 | 120 | 6 | 32538781 | |
| Pubmed | 1.38e-05 | 225 | 120 | 7 | 12168954 | ||
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 1.42e-05 | 14 | 120 | 3 | 28263302 | |
| Pubmed | TENT4B SFSWAP ATRX MAP4 NACA SPECC1L RAB11FIP1 GORASP2 CELSR1 MICALL2 ATXN2 SETD5 NFIB DROSHA KMT2A DNMBP AFF4 | 1.56e-05 | 1497 | 120 | 17 | 31527615 | |
| Pubmed | 1.59e-05 | 529 | 120 | 10 | 14621295 | ||
| Pubmed | 1.77e-05 | 15 | 120 | 3 | 30948508 | ||
| Pubmed | 1.77e-05 | 15 | 120 | 3 | 14697343 | ||
| Pubmed | 2.25e-05 | 335 | 120 | 8 | 15741177 | ||
| Pubmed | SOX4 SOX15 SALL3 LIMD1 RBM10 ZBTB22 SRCAP ARID1A EGR1 NFIB PAX2 CUX1 | 2.43e-05 | 808 | 120 | 12 | 20412781 | |
| Pubmed | RAPGEF6 GBF1 LIMD1 KIAA1549 SORBS1 RAB11FIP1 ARID1A LMO7 HGS | 2.58e-05 | 446 | 120 | 9 | 24255178 | |
| Pubmed | GBF1 KIAA1549 RAB11FIP1 POM121C ATF6 GORASP2 UBE2O HGS USP32 TJAP1 ROBO1 TMEM131 CUX1 | 2.63e-05 | 952 | 120 | 13 | 38569033 | |
| Pubmed | 2.79e-05 | 251 | 120 | 7 | 29778605 | ||
| Pubmed | 2.89e-05 | 347 | 120 | 8 | 17114649 | ||
| Pubmed | 2.91e-05 | 453 | 120 | 9 | 29656893 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.13e-05 | 351 | 120 | 8 | 38297188 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.16e-05 | 256 | 120 | 7 | 33397691 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.39e-05 | 462 | 120 | 9 | 31138677 | |
| Pubmed | 3.45e-05 | 106 | 120 | 5 | 18654987 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 1582411 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 33318575 | ||
| Pubmed | Mutation of SALL2 causes recessive ocular coloboma in humans and mice. | 3.53e-05 | 3 | 120 | 2 | 24412933 | |
| Pubmed | Suppression of Slit2/Robo1 mediated HUVEC migration by Robo4. | 3.53e-05 | 3 | 120 | 2 | 26713366 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 18948384 | ||
| Pubmed | ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity. | 3.53e-05 | 3 | 120 | 2 | 31895940 | |
| Pubmed | Teashirt 3 expression in the chick embryo reveals a remarkable association with tendon development. | 3.53e-05 | 3 | 120 | 2 | 16631416 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 14766215 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 9556594 | ||
| Pubmed | Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction. | 3.53e-05 | 3 | 120 | 2 | 19745106 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 22180456 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 22661412 | ||
| Pubmed | Repression of Pax-2 by WT1 during normal kidney development. | 3.53e-05 | 3 | 120 | 2 | 7720589 | |
| Pubmed | Expression of three spalt (sal) gene homologues in zebrafish embryos. | 3.53e-05 | 3 | 120 | 2 | 12590351 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 14973285 | ||
| Pubmed | SAFB regulates hippocampal stem cell fate by targeting Drosha to destabilize Nfib mRNA. | 3.53e-05 | 3 | 120 | 2 | 38722021 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 10588740 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 8034599 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.82e-05 | 361 | 120 | 8 | 26167880 | |
| Pubmed | TENT4B SFSWAP BCLAF1 RBM10 EVPL ZC3H18 SPECC1L LMO7 NFIB DROSHA KMT2A CUX1 | 3.84e-05 | 847 | 120 | 12 | 35850772 | |
| Pubmed | 4.06e-05 | 591 | 120 | 10 | 15231748 | ||
| Pubmed | 4.37e-05 | 20 | 120 | 3 | 38267260 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FBXW9 MYCBP2 ADRM1 TUT1 ZC3H18 FAF1 UBE2O LAT DCP1B YLPM1 USP32 ASXL2 NUP188 | 4.59e-05 | 1005 | 120 | 13 | 19615732 |
| Pubmed | 4.63e-05 | 371 | 120 | 8 | 15747579 | ||
| Pubmed | 5.09e-05 | 21 | 120 | 3 | 18547144 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.14e-05 | 608 | 120 | 10 | 36089195 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SOX4 ATRX MYCBP2 ADRM1 TBC1D25 RAB11FIP1 POM121C RNF214 TLK1 GORASP2 POM121 DCP1B LMO7 SETD5 TMEM184B | 5.16e-05 | 1321 | 120 | 15 | 27173435 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYCBP2 MAP4 BCLAF1 RBM10 NACA SPECC1L SRCAP PHLDB1 POM121 LMO7 GLE1 YLPM1 NUP188 | 5.55e-05 | 1024 | 120 | 13 | 24711643 |
| Pubmed | 6.52e-05 | 503 | 120 | 9 | 36217030 | ||
| Pubmed | Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways. | 6.75e-05 | 23 | 120 | 3 | 15229646 | |
| Pubmed | 6.82e-05 | 506 | 120 | 9 | 30890647 | ||
| Interaction | RNF43 interactions | LIMD1 RBM10 ITSN1 KIAA1549 ARID1A POM121C FAF1 GGA3 GORASP2 UBE2O POM121 ATXN2 HGS TMEM131 NUP188 DNMBP | 4.57e-09 | 427 | 119 | 16 | int:RNF43 |
| Interaction | TLE3 interactions | SOX15 TSHZ3 ARID1A LHX6 WAC ZNF503 POM121 EGR1 NFIB KMT2A PAX2 ASXL2 ELK3 CUX1 | 4.89e-08 | 376 | 119 | 14 | int:TLE3 |
| Interaction | TOP3B interactions | SOX4 RAPGEF6 GBF1 SH2B3 MYCBP2 TBC1D25 LRRK1 MED13L SRCAP ARID1A POM121C SH2B2 GGA3 ZNF503 TLK1 GORASP2 PHLDB1 CELSR1 ATXN2 SETD5 PAX2 NUP188 CABIN1 DNMBP LTBP4 PRRT4 | 3.50e-07 | 1470 | 119 | 26 | int:TOP3B |
| Interaction | LPXN interactions | 4.07e-07 | 115 | 119 | 8 | int:LPXN | |
| Interaction | WWTR1 interactions | RAPGEF6 LIMD1 MYCBP2 RBM10 SPECC1L SRCAP ARID1A GGA3 UBE2O LMO7 PRRC2C KMT2A CUX1 | 1.30e-06 | 422 | 119 | 13 | int:WWTR1 |
| Interaction | KHDRBS1 interactions | ITSN1 NCKAP5 SORBS1 FAF1 UBE2O MICALL2 ATXN2 GLE1 DROSHA ARMC5 YLPM1 DNMBP | 2.17e-06 | 373 | 119 | 12 | int:KHDRBS1 |
| Interaction | RPA4 interactions | TSHZ3 RAPGEF6 TENT4B LIMD1 MAP4 ADRM1 BCLAF1 RBM10 NACA ZC3H18 SALL2 PRRC2C CUX1 | 2.76e-06 | 452 | 119 | 13 | int:RPA4 |
| Interaction | SFN interactions | RAPGEF6 GBF1 MYCBP2 MAP4 COP1 ZC3H18 SORBS1 RAB11FIP1 MAP3K6 PHLDB1 NFATC3 LMO7 NFIB PRRC2C KMT2A DNMBP | 3.15e-06 | 692 | 119 | 16 | int:SFN |
| Interaction | YWHAE interactions | RAPGEF6 GBF1 ACD SH2B3 MYCBP2 RBM10 ZC3H18 SORBS1 RAB11FIP1 FAF1 MAP3K1 TLK1 PHLDB1 UBE2O DCP1B LMO7 SYN2 KMT2A FAM124A ASXL2 DNMBP | 1.34e-05 | 1256 | 119 | 21 | int:YWHAE |
| Interaction | ZFPL1 interactions | GBF1 ITSN1 KIAA1549 RAB11FIP1 FAF1 GGA3 GORASP2 HGS TJAP1 ROBO1 PRRT4 CUX1 | 1.39e-05 | 448 | 119 | 12 | int:ZFPL1 |
| Interaction | HNF1B interactions | 1.73e-05 | 190 | 119 | 8 | int:HNF1B | |
| Interaction | MKRN2 interactions | ATRX BCLAF1 ZC3H18 RNF214 UBE2O ATXN2 GLE1 NFIB PRRC2C ROBO1 PAX2 | 1.79e-05 | 385 | 119 | 11 | int:MKRN2 |
| Interaction | ATXN1L interactions | 3.07e-05 | 150 | 119 | 7 | int:ATXN1L | |
| Interaction | YWHAG interactions | RAPGEF6 GBF1 LIMD1 MYCBP2 BCLAF1 SORBS1 SPECC1L RAB11FIP1 MAP3K6 FAF1 MAP3K1 PHLDB1 DCP1B NFATC3 LMO7 PRRC2C SYN2 KMT2A FAM124A DNMBP | 4.05e-05 | 1248 | 119 | 20 | int:YWHAG |
| Interaction | NUP35 interactions | ARID1A POM121C ZNF503 POM121 DCP1B ATXN2 GLE1 NFIB PRRC2C YLPM1 NUP188 | 4.32e-05 | 424 | 119 | 11 | int:NUP35 |
| Interaction | JPH4 interactions | 5.11e-05 | 68 | 119 | 5 | int:JPH4 | |
| Interaction | NAA40 interactions | RAPGEF6 ATRX LIMD1 MAP4 BCLAF1 RBM10 NACA SRCAP POM121C WAC GGA3 GORASP2 UBE2O PRRC2C YLPM1 KMT2A AFF4 | 6.12e-05 | 978 | 119 | 17 | int:NAA40 |
| Interaction | PAX6 interactions | 6.35e-05 | 366 | 119 | 10 | int:PAX6 | |
| Interaction | NACA interactions | 7.60e-05 | 234 | 119 | 8 | int:NACA | |
| Interaction | EBAG9 interactions | 7.94e-05 | 303 | 119 | 9 | int:EBAG9 | |
| Interaction | YWHAH interactions | RAPGEF6 GBF1 SFSWAP LIMD1 MYCBP2 TBC1D25 SORBS1 SPECC1L RAB11FIP1 MAP3K6 FAF1 PHLDB1 DCP1B NFATC3 LMO7 PRRC2C KMT2A DNMBP | 8.10e-05 | 1102 | 119 | 18 | int:YWHAH |
| Interaction | YWHAZ interactions | RAPGEF6 GBF1 SH2B3 MYCBP2 COP1 ZC3H18 SORBS1 RAB11FIP1 ARID1A FAF1 MAP3K1 PHLDB1 DCP1B NFATC3 LMO7 SYN2 KMT2A FAM124A ASXL2 DNMBP | 8.74e-05 | 1319 | 119 | 20 | int:YWHAZ |
| Interaction | SIRT6 interactions | ATRX MYCBP2 BCLAF1 RBM10 SRCAP ARID1A POM121C FAF1 WAC CELSR1 POM121 YLPM1 NUP188 | 8.74e-05 | 628 | 119 | 13 | int:SIRT6 |
| Interaction | MEN1 interactions | TENT4B ATRX BCLAF1 RBM10 ZC3H18 SRCAP ARID1A POM121C WAC LMO7 NFIB DROSHA YLPM1 KMT2A NUP188 CUX1 AFF4 | 1.14e-04 | 1029 | 119 | 17 | int:MEN1 |
| Interaction | ASF1A interactions | 1.17e-04 | 249 | 119 | 8 | int:ASF1A | |
| Interaction | BICD1 interactions | 1.20e-04 | 250 | 119 | 8 | int:BICD1 | |
| Interaction | PABPN1 interactions | 1.46e-04 | 192 | 119 | 7 | int:PABPN1 | |
| Interaction | RBBP4 interactions | ROBO4 TSHZ3 SALL3 ADRM1 ITSN1 ZC3H18 ARID1A ARMC5 KMT2A ASXL2 CABIN1 CUX1 | 1.49e-04 | 573 | 119 | 12 | int:RBBP4 |
| Interaction | LSM14A interactions | 1.57e-04 | 260 | 119 | 8 | int:LSM14A | |
| Interaction | CSNK2A1 interactions | GBF1 ATRX BCLAF1 RBM10 NACA ZC3H18 FAF1 UBE2O DCP1B EGR1 ATXN2 PRRC2C HGS ZNF558 KMT2A ASXL2 | 1.59e-04 | 956 | 119 | 16 | int:CSNK2A1 |
| Interaction | FEV interactions | 2.05e-04 | 203 | 119 | 7 | int:FEV | |
| Interaction | CREBBP interactions | ATRX SRCAP ARID1A FAF1 HOXB2 HOXB3 NEUROG1 EGR1 NFIB DYRK1B KMT2A CUX1 | 2.24e-04 | 599 | 119 | 12 | int:CREBBP |
| Interaction | ZNF608 interactions | 2.27e-04 | 93 | 119 | 5 | int:ZNF608 | |
| Interaction | HNF4A interactions | 2.31e-04 | 275 | 119 | 8 | int:HNF4A | |
| Interaction | MYCBP2 interactions | 2.61e-04 | 355 | 119 | 9 | int:MYCBP2 | |
| GeneFamily | LIM domain containing | 1.28e-04 | 59 | 79 | 4 | 1218 | |
| GeneFamily | Nucleoporins | 3.63e-04 | 32 | 79 | 3 | 1051 | |
| GeneFamily | Non-canonical poly(A) polymerases | 3.90e-04 | 7 | 79 | 2 | 1318 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.91e-03 | 15 | 79 | 2 | 529 | |
| GeneFamily | SRY-boxes | 3.07e-03 | 19 | 79 | 2 | 757 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.02e-03 | 718 | 79 | 9 | 28 | |
| GeneFamily | PDZ domain containing | 4.43e-03 | 152 | 79 | 4 | 1220 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.89e-03 | 24 | 79 | 2 | 654 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATRX MYCBP2 ITSN1 SPECC1L MED13L TLK1 ATXN2 NFIB PRRC2C TMEM131 DNMBP CUX1 | 1.61e-06 | 466 | 120 | 12 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GBF1 ATRX MYCBP2 ITSN1 SPECC1L MED13L HOXB2 TLK1 ATXN2 NFATC3 MICAL2 NFIB PRRC2C TMEM131 DNMBP CUX1 | 1.90e-06 | 856 | 120 | 16 | M4500 |
| Coexpression | GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN | 3.23e-06 | 194 | 120 | 8 | M5767 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 2.45e-05 | 186 | 120 | 7 | M8175 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 3.77e-05 | 199 | 120 | 7 | M3474 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP | 3.90e-05 | 200 | 120 | 7 | M7649 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN | 3.90e-05 | 200 | 120 | 7 | M5234 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | TSHZ3 TSHZ2 ITSN1 RAB11FIP1 MAP3K1 PPARGC1B MICAL2 DNMBP LTBP4 | 6.81e-05 | 382 | 120 | 9 | M45756 |
| Coexpression | GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS | 7.30e-05 | 152 | 120 | 6 | M43614 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | SOX4 GBF1 SFSWAP ATRX BCLAF1 ITSN1 MED13L ARID1A FAF1 ZNF503 GORASP2 ATXN2 PRRC2C CUX1 | 7.13e-07 | 498 | 118 | 14 | gudmap_developingGonad_e11.5_testes_k5_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | SOX4 GBF1 SFSWAP ATRX BCLAF1 ITSN1 MED13L ARID1A FAF1 WAC ZNF503 TLK1 GORASP2 NEUROG1 ATXN2 GLE1 NFIB CUX1 | 9.55e-07 | 844 | 118 | 18 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | SOX4 GBF1 SFSWAP ATRX BCLAF1 ITSN1 MED13L ARID1A FAF1 ZNF503 GORASP2 NEUROG1 ATXN2 GLE1 PRRC2C CUX1 | 1.74e-05 | 843 | 118 | 16 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_200 | 3.85e-05 | 165 | 118 | 7 | gudmap_developingGonad_e12.5_testes_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | SOX4 GBF1 ATRX BCLAF1 ITSN1 MED13L ARID1A FAF1 ZNF503 GORASP2 ATXN2 CUX1 | 4.22e-05 | 533 | 118 | 12 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.41e-05 | 230 | 118 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 4.55e-05 | 231 | 118 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 6.13e-05 | 241 | 118 | 8 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_100 | 6.41e-05 | 39 | 118 | 4 | gudmap_developingGonad_e12.5_testes_k1_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.70e-05 | 249 | 118 | 8 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 9.09e-05 | 406 | 118 | 10 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 9.09e-05 | 406 | 118 | 10 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.01e-04 | 259 | 118 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_100 | 1.07e-04 | 17 | 118 | 3 | gudmap_developingGonad_e16.5_testes_100_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_200 | 1.07e-04 | 17 | 118 | 3 | gudmap_developingGonad_e12.5_testes_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 1.42e-04 | 203 | 118 | 7 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.43e-04 | 429 | 118 | 10 | gudmap_developingGonad_e14.5_ testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.47e-04 | 349 | 118 | 9 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#3_top-relative-expression-ranked_100 | 1.58e-04 | 49 | 118 | 4 | gudmap_developingGonad_e11.5_testes_k3_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.60e-04 | 435 | 118 | 10 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.61e-04 | 277 | 118 | 8 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | SOX4 GBF1 SFSWAP ATRX ARID1A FAF1 ZNF503 GORASP2 NEUROG1 GLE1 | 1.66e-04 | 437 | 118 | 10 | gudmap_developingGonad_e11.5_testes_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_100 | 1.71e-04 | 50 | 118 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.85e-04 | 212 | 118 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 1.93e-04 | 150 | 118 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 2.30e-04 | 99 | 118 | 5 | gudmap_developingGonad_e11.5_testes_k5_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | NCKAP5 IRX4 TLK1 GORASP2 MICALL2 LMO7 YLPM1 ROBO1 ASXL2 ELK3 | 3.39e-04 | 478 | 118 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | TSHZ3 RAPGEF6 ATRX MYCBP2 KIAA1549 SORBS1 IRAG1 NFIB PRRC2C SNTG2 ASXL2 CUX1 C4orf46 | 3.63e-04 | 772 | 118 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ATRX NCKAP5 SRCAP ARID1A WAC UBE2O SETD5 MICAL2 YLPM1 USP32 ASXL2 | 4.87e-04 | 595 | 118 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 4.90e-04 | 249 | 118 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 5.05e-04 | 413 | 118 | 9 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SOX4 SFSWAP ATRX MAP4 TSHZ2 BCLAF1 SRCAP MAP3K1 TLK1 ATXN2 NFIB PRRC2C LTBP4 | 5.15e-04 | 801 | 118 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SOX4 SFSWAP ATRX MAP4 BCLAF1 SRCAP ARID1A MAP3K1 ZNF503 ATXN2 NFIB PRRC2C ASXL2 | 5.33e-04 | 804 | 118 | 13 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | ROBO4 TSHZ3 TSHZ2 LHX6 ZNF503 HOXB2 HOXB3 PPARGC1B CELSR1 LAT NFIB ORAI3 PAX2 ELK3 TMEM184B LTBP4 | 5.88e-04 | 1143 | 118 | 16 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | SOX4 GBF1 SFSWAP ATRX ARID1A SH2B2 FAF1 WAC TLK1 GORASP2 GLE1 NFIB LTBP4 | 6.33e-04 | 819 | 118 | 13 | gudmap_developingGonad_P2_testes_1000 |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ROBO4 MYCBP2 MAP4 TSHZ2 ZNF503 PRRC2C KMT2A FAM124A ELK3 LTBP4 | 6.48e-11 | 180 | 120 | 10 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ROBO4 MYCBP2 MAP4 TSHZ2 ZNF503 PRRC2C KMT2A FAM124A ELK3 LTBP4 | 6.48e-11 | 180 | 120 | 10 | 423454e3390080ae03bb3cbb267255ebfe4df080 |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-08 | 181 | 120 | 8 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.33e-08 | 187 | 120 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-08 | 189 | 120 | 8 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.98e-08 | 195 | 120 | 8 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.22e-08 | 196 | 120 | 8 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.22e-08 | 196 | 120 | 8 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.22e-08 | 196 | 120 | 8 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.22e-08 | 196 | 120 | 8 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.47e-08 | 197 | 120 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.47e-08 | 197 | 120 | 8 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.00e-08 | 199 | 120 | 8 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.00e-08 | 199 | 120 | 8 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.16e-07 | 181 | 120 | 7 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-07 | 183 | 120 | 7 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-07 | 183 | 120 | 7 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.63e-07 | 183 | 120 | 7 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-07 | 184 | 120 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.13e-07 | 185 | 120 | 7 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-07 | 185 | 120 | 7 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.13e-07 | 185 | 120 | 7 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 186 | 120 | 7 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 186 | 120 | 7 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.15e-07 | 192 | 120 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 193 | 120 | 7 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 193 | 120 | 7 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.80e-07 | 194 | 120 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-06 | 197 | 120 | 7 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-06 | 197 | 120 | 7 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-06 | 198 | 120 | 7 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-06 | 199 | 120 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-06 | 200 | 120 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-06 | 200 | 120 | 7 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | wk_08-11-Mesenchymal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.20e-06 | 200 | 120 | 7 | 91416639e69621c5b36eebf061d81bccfe66f135 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.95e-06 | 166 | 120 | 6 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.95e-06 | 166 | 120 | 6 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 173 | 120 | 6 | 5d7c53c6d1cdd385e44b79b82faec901747d1736 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-06 | 178 | 120 | 6 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.04e-05 | 183 | 120 | 6 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 186 | 120 | 6 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.14e-05 | 186 | 120 | 6 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.14e-05 | 186 | 120 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 187 | 120 | 6 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.17e-05 | 187 | 120 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 188 | 120 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 188 | 120 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.25e-05 | 189 | 120 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-05 | 190 | 120 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 190 | 120 | 6 | 8f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 192 | 120 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 192 | 120 | 6 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 193 | 120 | 6 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.40e-05 | 193 | 120 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 193 | 120 | 6 | 07ddb9525b686c31fa7df4286557d1e58f7ead52 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 194 | 120 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 194 | 120 | 6 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 194 | 120 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 194 | 120 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 194 | 120 | 6 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 194 | 120 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 194 | 120 | 6 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-05 | 195 | 120 | 6 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.49e-05 | 195 | 120 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-05 | 195 | 120 | 6 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 196 | 120 | 6 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | 15-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 1.53e-05 | 196 | 120 | 6 | b8d95b5f4780e73d16dcc528e70a5496f0314373 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 196 | 120 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 196 | 120 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 196 | 120 | 6 | 74093f85e095606d1c723e0d7c2d78d9cfa47c4f | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 196 | 120 | 6 | d4df86ce289835e76763213641989fde77935a16 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.58e-05 | 197 | 120 | 6 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 197 | 120 | 6 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 197 | 120 | 6 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-05 | 197 | 120 | 6 | 05e303fff86db31f7b742324c64980eb2b9cff9a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-05 | 197 | 120 | 6 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-05 | 197 | 120 | 6 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 198 | 120 | 6 | ce59ee3d970397eb62d6387699c6c6cd65457898 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 198 | 120 | 6 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | 11.5-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 1.62e-05 | 198 | 120 | 6 | 5c606d881f151404287d9b43c9490e9bb486ef54 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 198 | 120 | 6 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-05 | 198 | 120 | 6 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.62e-05 | 198 | 120 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.67e-05 | 199 | 120 | 6 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.67e-05 | 199 | 120 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligodendroglioma-7|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.71e-05 | 118 | 120 | 5 | 42aa4d8975cec034802ff94aa8867d70c0a4d7b8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.72e-05 | 200 | 120 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | wk_15-18-Mesenchymal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.72e-05 | 200 | 120 | 6 | 4d484260ecbbbd9f820b445bdcc2666f6c464b73 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.72e-05 | 200 | 120 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-05 | 200 | 120 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | a372ef3f9e6ff6e3c3376d6e10182977c5067788 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-05 | 129 | 120 | 5 | 64768adf23123b92280fb30eb85147cbee084ae0 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.93e-05 | 132 | 120 | 5 | 6a6718582edfc59c63f2c8f753be81e0f4a7246b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 154 | 120 | 5 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 154 | 120 | 5 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| Drug | WY-14643; Down 200; 100uM; PC3; HG-U133A | 7.78e-07 | 192 | 119 | 9 | 464_DN | |
| Drug | rosiglitazone maleate; Down 200; 10uM; PC3; HG-U133A | 8.49e-07 | 194 | 119 | 9 | 430_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 9.64e-07 | 197 | 119 | 9 | 5564_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; HL60; HG-U133A | SFSWAP NACA MED13L RAB11FIP1 ARID1A EGR1 ATXN2 CABIN1 TMEM184B | 1.01e-06 | 198 | 119 | 9 | 1601_DN |
| Drug | Piromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 8.73e-06 | 195 | 119 | 8 | 3335_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; HL60; HT_HG-U133A | 9.41e-06 | 197 | 119 | 8 | 2902_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A | 9.41e-06 | 197 | 119 | 8 | 6306_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A | 9.41e-06 | 197 | 119 | 8 | 1210_UP | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 9.41e-06 | 197 | 119 | 8 | 6703_UP | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; HL60; HT_HG-U133A | 9.76e-06 | 198 | 119 | 8 | 2154_UP | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; HL60; HT_HG-U133A | 9.76e-06 | 198 | 119 | 8 | 2432_UP | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; HL60; HT_HG-U133A | 9.76e-06 | 198 | 119 | 8 | 3022_UP | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; HL60; HG-U133A | 1.01e-05 | 199 | 119 | 8 | 2027_UP | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; PC3; HT_HG-U133A | 1.01e-05 | 199 | 119 | 8 | 4259_UP | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.41e-05 | 179 | 119 | 7 | 4585_DN | |
| Drug | AC1O43PA | 4.86e-05 | 14 | 119 | 3 | CID006323294 | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.25e-05 | 184 | 119 | 7 | 1540_UP | |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.43e-05 | 190 | 119 | 7 | 3888_UP | |
| Drug | ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A | 6.87e-05 | 192 | 119 | 7 | 4429_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A | 7.10e-05 | 193 | 119 | 7 | 3378_DN | |
| Drug | pararosaniline base; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 7.10e-05 | 193 | 119 | 7 | 893_DN | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 7.33e-05 | 194 | 119 | 7 | 1307_DN | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 7.33e-05 | 194 | 119 | 7 | 4422_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 7.33e-05 | 194 | 119 | 7 | 1264_DN | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 6059_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 4393_DN | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 2727_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 1273_UP | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 2440_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 7419_DN | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 6062_UP | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 2056_DN | |
| Drug | monastrol; Down 200; 100uM; MCF7; HG-U133A | 7.82e-05 | 196 | 119 | 7 | 610_DN | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 3679_DN | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 3461_UP | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; PC3; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 3994_UP | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; HL60; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 2541_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A | 8.07e-05 | 197 | 119 | 7 | 1941_DN | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 3463_UP | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; PC3; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 4559_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 7185_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 7375_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 3904_UP | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; PC3; HG-U133A | 8.33e-05 | 198 | 119 | 7 | 664_DN | |
| Drug | ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 6165_UP | |
| Drug | arachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A | 8.33e-05 | 198 | 119 | 7 | 594_DN | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; PC3; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 4621_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; PC3; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 5870_UP | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; HL60; HG-U133A | 8.60e-05 | 199 | 119 | 7 | 2021_UP | |
| Drug | Gliquidone [33342-05-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 6004_UP | |
| Drug | Lisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 7403_DN | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HG-U133A | 8.60e-05 | 199 | 119 | 7 | 1893_UP | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; HL60; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 1281_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 3833_UP | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 7480_UP | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 2116_UP | |
| Drug | Fipexide hydrochloride [34161-23-4]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 3176_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 3405_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 3619_UP | |
| Drug | LS-93106 | 1.61e-04 | 4 | 119 | 2 | CID003029408 | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.34e-04 | 165 | 119 | 6 | 3851_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.41e-04 | 166 | 119 | 6 | 3283_UP | |
| Drug | Asbestos, Crocidolite | SOX4 RAPGEF6 ITSN1 DUSP9 IRAG1 ARID1A HCN2 MAP3K6 FAF1 ATF6 PPARGC1B LAT EGR1 DYRK1B ROBO1 DNMBP AFF4 | 2.49e-04 | 1241 | 119 | 17 | ctd:D017638 |
| Drug | Rim-1 | 2.68e-04 | 5 | 119 | 2 | CID003081320 | |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.83e-04 | 171 | 119 | 6 | 3297_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.11e-04 | 174 | 119 | 6 | 5693_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.41e-04 | 177 | 119 | 6 | 985_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.51e-04 | 178 | 119 | 6 | 3998_DN | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 3.84e-04 | 181 | 119 | 6 | 6220_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 3.84e-04 | 181 | 119 | 6 | 1236_UP | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.95e-04 | 182 | 119 | 6 | 4989_UP | |
| Drug | AC1L85AO | 3.98e-04 | 66 | 119 | 4 | CID000372705 | |
| Drug | bismuth aluminate | 4.01e-04 | 6 | 119 | 2 | CID000166681 | |
| Drug | AC1L4GYE | 4.01e-04 | 6 | 119 | 2 | CID000156861 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 4.07e-04 | 183 | 119 | 6 | 6946_UP | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 4.19e-04 | 184 | 119 | 6 | 2696_UP | |
| Drug | AC1L1DW2 | 4.43e-04 | 186 | 119 | 6 | CID000002532 | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.43e-04 | 186 | 119 | 6 | 2218_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.69e-04 | 188 | 119 | 6 | 6735_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 4.82e-04 | 189 | 119 | 6 | 4271_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 5.10e-04 | 191 | 119 | 6 | 2850_DN | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; PC3; HT_HG-U133A | 5.10e-04 | 191 | 119 | 6 | 4614_UP | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | 5.10e-04 | 191 | 119 | 6 | 1813_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 5.10e-04 | 191 | 119 | 6 | 4442_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 5.10e-04 | 191 | 119 | 6 | 6020_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A | 5.10e-04 | 191 | 119 | 6 | 3123_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.24e-04 | 192 | 119 | 6 | 3929_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.24e-04 | 192 | 119 | 6 | 3925_DN | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; PC3; HT_HG-U133A | 5.39e-04 | 193 | 119 | 6 | 6331_DN | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A | 5.39e-04 | 193 | 119 | 6 | 2505_DN | |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; HL60; HG-U133A | 5.39e-04 | 193 | 119 | 6 | 1749_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A | 5.54e-04 | 194 | 119 | 6 | 2824_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; HL60; HG-U133A | 5.54e-04 | 194 | 119 | 6 | 2042_DN | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A | 5.54e-04 | 194 | 119 | 6 | 1712_DN | |
| Drug | ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A | 5.54e-04 | 194 | 119 | 6 | 6165_DN | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A | 5.54e-04 | 194 | 119 | 6 | 1547_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 5.54e-04 | 194 | 119 | 6 | 4361_DN | |
| Drug | covellite | 5.59e-04 | 7 | 119 | 2 | CID000014831 | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; PC3; HT_HG-U133A | 5.69e-04 | 195 | 119 | 6 | 6626_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 10uM; MCF7; HG-U133A | 5.69e-04 | 195 | 119 | 6 | 405_DN | |
| Disease | Adenoid Cystic Carcinoma | 1.70e-07 | 100 | 119 | 7 | C0010606 | |
| Disease | serum gamma-glutamyl transferase measurement | ATRX MARCHF8 FAM131C SPECC1L ARID1A POM121C FAF1 POM121 NFIB SYN2 KMT2A ROBO1 PAX2 CABIN1 DNMBP MUC6 | 8.62e-07 | 914 | 119 | 16 | EFO_0004532 |
| Disease | C-X-C motif chemokine 11 measurement | 2.25e-05 | 14 | 119 | 3 | EFO_0008057 | |
| Disease | Neurodevelopmental Disorders | 3.84e-05 | 93 | 119 | 5 | C1535926 | |
| Disease | C-X-C motif chemokine 9 measurement | 4.83e-05 | 3 | 119 | 2 | EFO_0022032 | |
| Disease | nt-3 growth factor receptor measurement | 4.83e-05 | 3 | 119 | 2 | EFO_0020613 | |
| Disease | blood urea nitrogen measurement | 9.38e-05 | 452 | 119 | 9 | EFO_0004741 | |
| Disease | natural killer cell receptor 2B4 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0021882 | |
| Disease | X-12100 measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0800701 | |
| Disease | semaphorin-4D measurement | 9.63e-05 | 4 | 119 | 2 | EFO_0802050 | |
| Disease | cardiovascular disease | 1.02e-04 | 457 | 119 | 9 | EFO_0000319 | |
| Disease | cortical surface area measurement | MYCBP2 NCKAP5 MED13L IRAG1 FAF1 MAP3K1 CELSR1 ATXN2 NFIB PRRC2C KIAA1755 ROBO1 PAX2 ELK3 PRDM6 CUX1 | 1.02e-04 | 1345 | 119 | 16 | EFO_0010736 |
| Disease | CXCL11 measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0010779 | |
| Disease | cortical thickness | MYCBP2 NCKAP5 IRAG1 FAF1 MAP3K1 PHLDB1 CELSR1 ATXN2 SETD5 YLPM1 KIAA1755 KMT2A ROBO1 TMEM131 | 1.62e-04 | 1113 | 119 | 14 | EFO_0004840 |
| Disease | brain disease (implicated_via_orthology) | 2.39e-04 | 6 | 119 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | eicosapentaenoic acid measurement | 2.65e-04 | 31 | 119 | 3 | EFO_0007760 | |
| Disease | Dental enamel hypoplasia, dental caries, tooth agenesis | 3.34e-04 | 7 | 119 | 2 | EFO_0003819, EFO_0005410, EFO_1001304 | |
| Disease | vascular cell adhesion protein 1 measurement | 3.34e-04 | 7 | 119 | 2 | EFO_0020846 | |
| Disease | reticulocyte measurement | SH2B3 MARCHF8 FAF1 MAP3K1 UBE2O ATXN2 MICAL2 USP32 SYN2 TMEM131 ASXL2 BSN CUX1 | 3.35e-04 | 1053 | 119 | 13 | EFO_0010700 |
| Disease | lung adenocarcinoma (is_marker_for) | 3.96e-04 | 85 | 119 | 4 | DOID:3910 (is_marker_for) | |
| Disease | Burkitt Lymphoma | 4.14e-04 | 36 | 119 | 3 | C0006413 | |
| Disease | myelofibrosis (is_implicated_in) | 4.44e-04 | 8 | 119 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | mammographic density percentage, mammographic density measurement | 4.44e-04 | 8 | 119 | 2 | EFO_0005941, EFO_0006502 | |
| Disease | Cornelia De Lange Syndrome | 4.44e-04 | 8 | 119 | 2 | C0270972 | |
| Disease | t-cell surface glycoprotein CD5 measurement | 5.70e-04 | 9 | 119 | 2 | EFO_0803134 | |
| Disease | latent autoimmune diabetes in adults, type 2 diabetes mellitus | 5.70e-04 | 9 | 119 | 2 | EFO_0009706, MONDO_0005148 | |
| Disease | colorectal cancer, endometrial neoplasm | 6.55e-04 | 42 | 119 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | beta-2 microglobulin measurement | 8.66e-04 | 11 | 119 | 2 | EFO_0005197 | |
| Disease | right ventricular stroke volume measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0021817 | |
| Disease | event free survival time, type 1 diabetes mellitus, autoantibody measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0000482, EFO_0004866, MONDO_0005147 | |
| Disease | reticulocyte count | SH2B3 MARCHF8 MAP3K1 UBE2O ATXN2 MICAL2 USP32 SYN2 TMEM131 ASXL2 BSN CUX1 | 1.07e-03 | 1045 | 119 | 12 | EFO_0007986 |
| Disease | Coffin-Siris syndrome | 1.22e-03 | 13 | 119 | 2 | C0265338 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 1.22e-03 | 52 | 119 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | neuroimaging measurement | DUSP9 NCKAP5 IRAG1 POM121C FAF1 MAP3K1 CELSR1 ATXN2 NFIB PRRC2C KIAA1755 ROBO1 | 1.30e-03 | 1069 | 119 | 12 | EFO_0004346 |
| Disease | QRS duration | 1.35e-03 | 298 | 119 | 6 | EFO_0005055 | |
| Disease | peripheral arterial disease | 1.37e-03 | 54 | 119 | 3 | EFO_0004265 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 1.42e-03 | 14 | 119 | 2 | EFO_0008212 | |
| Disease | obsolete_interleukin-12 subunit B measurement | 1.42e-03 | 14 | 119 | 2 | EFO_0010787 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.44e-03 | 55 | 119 | 3 | EFO_0004623, HP_0002140 | |
| Disease | heart rate response to recovery post exercise | 1.60e-03 | 57 | 119 | 3 | EFO_0009185 | |
| Disease | African Burkitt's lymphoma | 1.64e-03 | 15 | 119 | 2 | C0343640 | |
| Disease | tumor necrosis factor measurement | 1.64e-03 | 15 | 119 | 2 | EFO_0010834 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 1.64e-03 | 15 | 119 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Burkitt Leukemia | 1.64e-03 | 15 | 119 | 2 | C4721444 | |
| Disease | pre-eclampsia (is_marker_for) | 1.68e-03 | 58 | 119 | 3 | DOID:10591 (is_marker_for) | |
| Disease | lung small cell carcinoma (is_marker_for) | 1.87e-03 | 16 | 119 | 2 | DOID:5409 (is_marker_for) | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 1.87e-03 | 16 | 119 | 2 | EFO_0004792, HP_0002140 | |
| Disease | thyroid stimulating hormone measurement | 2.02e-03 | 323 | 119 | 6 | EFO_0004748 | |
| Disease | cutaneous melanoma, hair color | 2.03e-03 | 62 | 119 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | factor XI measurement, Ischemic stroke | 2.11e-03 | 17 | 119 | 2 | EFO_0004694, HP_0002140 | |
| Disease | Headache | 2.23e-03 | 64 | 119 | 3 | HP_0002315 | |
| Disease | apolipoprotein A 1 measurement | SH2B3 TSHZ2 MARCHF8 ARID1A RNF214 PPARGC1B ATXN2 NFATC3 YLPM1 KMT2A | 2.32e-03 | 848 | 119 | 10 | EFO_0004614 |
| Disease | creatinine measurement | DUSP9 ARID1A SH2B2 MICALL2 PRRC2C USP32 SYN2 KIAA1755 ASXL2 BSN CUX1 | 2.33e-03 | 995 | 119 | 11 | EFO_0004518 |
| Disease | C-C motif chemokine 3 measurement | 2.37e-03 | 18 | 119 | 2 | EFO_0008051 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.54e-03 | 67 | 119 | 3 | C3463824 | |
| Disease | hematocrit | SH2B3 DUSP9 SORBS1 IRAG1 MICALL2 ATXN2 SYN2 ORAI3 ASXL2 BSN LTBP4 | 2.64e-03 | 1011 | 119 | 11 | EFO_0004348 |
| Disease | dense area measurement, mammographic density measurement | 2.64e-03 | 19 | 119 | 2 | EFO_0005941, EFO_0006503 | |
| Disease | factor VIII measurement, Ischemic stroke | 2.64e-03 | 19 | 119 | 2 | EFO_0004630, HP_0002140 | |
| Disease | serum alanine aminotransferase measurement | RAPGEF6 GBF1 SH2B3 FAM131C ARID1A POM121C MAP3K1 ATXN2 SYN2 DNMBP | 2.77e-03 | 869 | 119 | 10 | EFO_0004735 |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 2.89e-03 | 239 | 119 | 5 | EFO_0010934 | |
| Disease | acetate measurement | 2.92e-03 | 20 | 119 | 2 | EFO_0010112 | |
| Disease | Autoimmune Hepatitis | 3.22e-03 | 21 | 119 | 2 | EFO_0005676 | |
| Disease | neutrophil percentage of leukocytes | 3.36e-03 | 610 | 119 | 8 | EFO_0007990 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.50e-03 | 75 | 119 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | serum non-albumin protein measurement | 3.51e-03 | 361 | 119 | 6 | EFO_0004568 | |
| Disease | glaucoma | 3.56e-03 | 154 | 119 | 4 | MONDO_0005041 | |
| Disease | parental longevity | 3.96e-03 | 494 | 119 | 7 | EFO_0007796 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPASAASKSPAGSTP | 391 | P30926 | |
| LSSSPSPPSVAVSAA | 31 | Q8NHY2 | |
| SSAPPPSNSSSSSAP | 1436 | P39880 | |
| PPSSPSSSDASAASS | 16 | Q504U0 | |
| KSTCPSAAPSASAPA | 76 | Q69YQ0 | |
| SAPSSAASGASSPAP | 91 | Q96C12 | |
| ASGPAPSAVSSSSPT | 106 | Q96C12 | |
| SLNPSNSESSPSRCP | 1421 | Q6XZF7 | |
| ASSAFSPASPATPNG | 91 | Q53GS7 | |
| QPLSPASSSYSVSSP | 91 | P18850 | |
| EAATAGTPSASPSPS | 201 | Q9NYQ6 | |
| SSIATSAANPSPLTP | 16 | Q96F81 | |
| SSASTSPAPLDTCPS | 446 | Q9Y463 | |
| SPAPLDTCPSSSTAS | 451 | Q9Y463 | |
| AGSAPPSSTLPAASS | 911 | Q76L83 | |
| KAPSSSSNCPPSAPT | 881 | Q9UHB7 | |
| SSALPPATSPTAQES | 546 | P98175 | |
| SASPQDSSPRLSTFP | 326 | O00712 | |
| AAPAAVSSAPATSPS | 401 | P78413 | |
| PASNLPRSSASAAPS | 206 | Q9BRQ5 | |
| SASPTDVSSNPFLPS | 371 | Q9HCM3 | |
| ASPSQSLSPAPSLES | 41 | A6NI15 | |
| AAGSKPPPSSSASAS | 246 | O14497 | |
| SASSPPSASSSPHPS | 46 | Q8NDF8 | |
| SVSASPLFPSSPAAS | 2191 | Q6W4X9 | |
| SQLSTPAASPSASEP | 51 | Q5XUX1 | |
| PPAGSAFNPTSNSSS | 1556 | Q71F56 | |
| ASPSKPASAPASRSG | 786 | P27816 | |
| PSFPLVPESSSAASS | 366 | Q9H8Y8 | |
| PKSYLSSSAPSSSPA | 341 | Q9UGP4 | |
| AAASPLSDPSSPAAS | 191 | Q92886 | |
| QAARSPSSLPSSPAS | 1851 | Q38SD2 | |
| SSPRLSPASPAAAAS | 421 | Q5JYT7 | |
| ATSTAAPSAPALSTP | 171 | O43561 | |
| ASPAAAPSPSSSSVS | 206 | Q99700 | |
| NSSSPSRSPGLSPSS | 436 | Q86X51 | |
| TAEFSTQTPSPAPAS | 1501 | Q9UPA5 | |
| NSSASRSPSLALSPP | 551 | Q5VYM1 | |
| NPPASSSSAPSPAAS | 166 | P18146 | |
| SPAASSASASQSPPL | 176 | P18146 | |
| SASASQSPPLSCAVP | 181 | P18146 | |
| SATARAAPPAPSTST | 491 | Q86V42 | |
| PNLSPSASPTSSRSN | 186 | Q9Y6F6 | |
| DAPSASPTPSANSTT | 926 | O95382 | |
| PPAPLSTSSTSQASA | 516 | Q8IY33 | |
| LASPAPQSTSFFSPS | 1801 | Q92817 | |
| LSQSDPSPSPNSCSS | 11 | O94830 | |
| SAASNPPSFFTTPTS | 361 | Q99956 | |
| TPAPSPDASQLASSL | 956 | Q8WWI1 | |
| PSASAPAPVSSFSRT | 56 | Q5T0T0 | |
| SVCSPPSAASSVPSA | 51 | Q9UPM6 | |
| ASDAPLLQPSAPSSS | 441 | Q9NZ52 | |
| LLQPSAPSSSSSQAP | 446 | Q9NZ52 | |
| VPSTASPPVSSASND | 166 | Q02962 | |
| STLSSPSSNAPDPCA | 271 | A8CG34 | |
| RNGPSSSPFSSPASS | 406 | A8CG34 | |
| TFTLPAAATASPPTS | 551 | A8CG34 | |
| AAATASPPTSLLAPS | 556 | A8CG34 | |
| QNTSPSSPAAPAASS | 686 | A8CG34 | |
| PSSSPFSSPASSRSQ | 16 | A6NF01 | |
| SPSSPAAPAASSASP | 296 | A6NF01 | |
| PRPASLSSASSTPAS | 71 | Q9NQX0 | |
| KPSQSATSPSPAASA | 106 | P14652 | |
| TSPSSPAAPAASSAP | 711 | Q96HA1 | |
| TPFNSPASKSDSPSV | 541 | Q9BWT3 | |
| PSTPAPASSAALNRS | 371 | Q8IZD4 | |
| SKATSSSNPSSPAPD | 1986 | P46100 | |
| ASETQPLSSPPTAAS | 2086 | Q9Y6J0 | |
| PIATPPSQSSSCSDA | 231 | Q9NYF8 | |
| SSQAPPSPFSPDASS | 1941 | Q9P0X4 | |
| SAFTPATATGSSPSP | 891 | Q15811 | |
| DSLQAFSSPSPSPDS | 206 | Q96AQ9 | |
| PPSAAPTSATSNSSN | 91 | P14651 | |
| ASPFSSRSPSLSPNS | 236 | P41970 | |
| FAAATSAASPSPSPS | 21 | Q8N2S1 | |
| AASSSSPGSPVASSP | 1776 | Q92538 | |
| NPSLPTSQSLFPSAS | 3136 | Q03164 | |
| FNPASHPASAPTSSS | 66 | Q9UNN5 | |
| ASGAPTTSAPAPSSS | 611 | Q9Y467 | |
| TTSAPAPSSSASSGP | 616 | Q9Y467 | |
| SAASSQPQSASTPPA | 331 | Q9BXA9 | |
| APGPAASTRPASSST | 831 | Q9UL51 | |
| AGPASSSTTAPAPRS | 531 | Q9NT99 | |
| PAASSSPSTVDSASP | 911 | O94851 | |
| QPLFLAASPPASSTS | 76 | Q13233 | |
| PSSSSSLAEAQPPLA | 511 | Q92777 | |
| SPSVFSSLSSPIAAP | 591 | Q6WKZ4 | |
| PSAPSTTFSNSPAPN | 56 | Q9NRR4 | |
| AASPAPSSAPSHASS | 366 | Q06945 | |
| SSSSAANTNPAVAPP | 616 | Q12872 | |
| ASSLHSSPPASPQGS | 1231 | Q8TEU7 | |
| LSSFSHPDSPSSSSP | 551 | Q3MII6 | |
| SSSSSAPAAAPPGAI | 231 | A6NKL6 | |
| DPASPTTAAASPSVS | 11 | Q9Y519 | |
| NSSTESSPNKAPSAP | 1316 | O14513 | |
| STSPGSSAPIAPSAS | 31 | Q12837 | |
| SSAPIAPSASSPSSS | 36 | Q12837 | |
| AAITSSSAPASAPAP | 1826 | Q9Y520 | |
| SALASTSAPTPAPAA | 1866 | Q9Y520 | |
| SAPTASVPLAPASAS | 1896 | Q9Y520 | |
| ALSCTSASPAPSSAP | 121 | Q86YN6 | |
| PSSAASPTLQGPSDS | 1341 | Q9C0A6 | |
| TLPANRSSPSGASSP | 2826 | O75592 | |
| SASGLNPTSAPPTSA | 326 | Q9BTA9 | |
| NGNSSTTAPSSPSSP | 191 | Q9NY99 | |
| GSNPVSPASSSSPAS | 26 | Q6ZRS2 | |
| PSLAPSGASPSASAL | 1491 | Q6ZRS2 | |
| SPQASSLSGPSPASS | 761 | Q8WZ75 | |
| SSSQPSPAICSAPAT | 311 | Q96AP0 | |
| ASASTPAQAPTSDSP | 46 | P55789 | |
| PSAPAAASATSPSPA | 231 | Q16186 | |
| AASATSPSPAPSSGN | 236 | Q16186 | |
| SPAPLTLSAPASSAS | 391 | Q5JTD0 | |
| ANAPSPPESSSLCAS | 11 | Q8ND24 | |
| SSSVRPNSPSPTALA | 181 | Q9UKI8 | |
| PPAATAAASSSSGPQ | 16 | O60248 | |
| SSSSAAPPTPASSSS | 16 | Q8N377 | |
| ASSSSAAPPTPASSS | 26 | Q8N377 | |
| PASSSSAAPPTPANC | 36 | Q8N377 | |
| STAAPPTPANCSTAA | 51 | Q8N377 | |
| PSSSLAPQTPDSALA | 281 | Q9H6E5 | |
| LPSTAAPSSLFPASQ | 6 | Q96NG5 | |
| PFSSSPSRSATASPQ | 941 | Q9BX66 | |
| SNPSSPDFTPLNSFS | 1711 | Q92545 | |
| PSASSAPPASSLYSS | 296 | O14964 | |
| APPASSLYSSPVNSS | 301 | O14964 | |
| PAPASDSASGPSSDS | 36 | Q9C0C9 | |
| ASPAASHPLASSPLS | 926 | Q12968 | |
| PPSAASAAPSSSKQP | 1521 | Q5SRE5 | |
| SSPSPLDPAASLSFA | 271 | C9JH25 | |
| LQPSSPSSAPSASPA | 6 | Q9UQQ2 | |
| PPASPSDAAGASSSS | 556 | O14492 | |
| TFPTSNNPRDPSSSS | 1591 | Q9Y6N7 | |
| TSPAFSPLSSPASSG | 251 | Q86UU1 | |
| PNSDSLAPKPSSNSA | 436 | Q9NRE2 | |
| PLAATTFTSPSNTPA | 446 | Q63HK5 | |
| LTAAPVPPASSSQSS | 646 | P49750 | |
| PSSLSSSQASEPLCP | 16 | Q8NA96 | |
| PFTPRTGSPSSSASA | 221 | Q96F45 | |
| SSSSSSSSQAPGQPP | 431 | O15209 | |
| SCPSSKNSSPNSSPR | 1386 | Q8NFA0 | |
| ASPVSSASSRSPAPA | 736 | Q86VM9 | |
| APKNSPSFQSTSSSP | 566 | E9PAV3 |